Alessia Romagnoli

7PUBLICATIONS
4CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Artificial life and complex adaptive systemsOncology and carcinogenesis not elsewhere classifiedToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
Statin deprescribing: a comprehensive review and development of a clinical algorithm for optimal patient management.

Tiziano Lupi, Fabio Esposito, Alessia Romagnoli

|Feb 27, 2025
Adherence and persistence rates for antidiabetic treatments in type 2 diabetes: a real-world study in an Italian region.

Alessia Romagnoli, Martina Savoia, Gloria Papini

|Mar 05, 2024
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework.

Alessia Romagnoli, Francesco Ferrara, Roberto Langella

|Jan 20, 2024
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.

Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri

|Jan 08, 2024
Antidepressant deprescribing: State of the art and recommendations-A literature overview.

Alessia Romagnoli, Andrea Zovi, Fiorenzo Santoleri

|Aug 12, 2022
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years.

Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini

Pageof 2